Navigation Links
Too much water may be as dangerous as too little during long-distance athletic events

Drinking water during a long-distance race may do serious harm rather than keep you safe from injury if you're drinking too much, according to a cardiologist at UT Southwestern Medical Center.

Runners or any long-distance athletes who drink too much water during a race could put themselves at jeopardy for developing hyponatremia, a condition marked by a loss in the body's sodium content that can result in physical symptoms such as lethargy, disorientation, seizures and even respiratory distress.

In a perspectives article in the current issue of The New England Journal of Medicine, Dr. Benjamin Levine, professor of internal medicine at UT Southwestern, said competitive runners are less likely to suffer from hyponatremia.

"Those who are running to finish the race very fast don't have time to drink a lot of water along the way," Dr. Levine said. "Those who are not running the race competitively tend to stop at every water station and take a drink. Over the course of a long race, they can dilute themselves."

In addition popular sports drinks don't always include enough sodium to offset the body's loss of the mineral during exercise. The drinks often carry more water with smaller concentrations of salts than are normally found in the human body; therefore, they do not replace salts adequately, said Dr. Levine, medical director of the Institute for Exercise and Environmental Medicine, a collaboration between UT Southwestern and Presbyterian Hospital of Dallas.

The NEJM perspectives article accompanies a study in the same journal by researchers at Children's Hospital in Boston and Harvard Medical School. The study evaluates the blood concentration of sodium in runners both before and after a long race and examines their risk factors for developing hyponatremia. It recommends individualized fluid-replacement consumption by all competing athletes.

"Researchers of the study found a surprisingly large number of runners had actuall
'"/>

Source:UT Southwestern


Page: 1 2

Related biology news :

1. Anti-bacterial additive widespread in U.S. waterways
2. Unprecedented water level rise in Somalia
3. Microbial fuel cell: High yield hydrogen source and wastewater cleaner
4. Survey finds silver contamination in North Pacific waters
5. Researchers discover underwater volcano
6. Radio-tracking associated with dramatic shift in water vole sex ratio
7. Major new UNC-based drinking water study suggests pregnancy fears may be overstated
8. Newly discovered genetic disease sheds light on bodys water balance
9. Beetle-inspired switch uses water for bonding
10. UNC computer, marine scientists collaborate to predict flow of toxic waters from Katrina
11. Acid water in East Java threatens biodiversity and local welfare
Post Your Comments:
(Date:7/8/2008)...o stay fit, do their bit for the environment or av...eir health if they don,t choose the right bicycle....al surgeon Mr Vinod Nargund from St Bartholomew,s ...rnal BJU International . , He says that the pro...ection problems and soreness and skin irritations ...
(Date:7/8/2008)... . , Barcelona, Spain: Couples who need IVF... this will not lead to developmental problems in e...ual conference of the European Society of Human Re...Dr. Karin Middelburg, from the University Medical ... that the study, which looked at the quality of ge...
(Date:7/8/2008)... . , Barcelona, Spain: Children born after ...omb have higher birth weight than those born where...ed to the 24th annual conference of the European S...(Tuesday 8 July). The mothers had longer pregnanci...k of congenital malformations, said Dr. Anja Pinbo...
(Date:7/7/2008)...U.S. coral reef ecosystems are considered to be in...A analysis of the health of coral reefs under U.S....tate of Coral Reef Ecosystems of the United States...that the nation,s coral reef ecosystems, particula... face intense human-derived threats from coastal d...
Breaking Biology News(10 mins):Male cyclists risk sexual problems if they don’t choose the right bike 2IVF does not increase risk of developmental disorders in children 2Children born from frozen embryos weigh more and do better than those born after fresh transfer 2NOAA report states half of US coral reefs in 'poor' or 'fair' condition 2New insight into RA patient priorities and motivators for clinical trial involvement 21796 1New insight into RA patient priorities and motivators for clinical trial involvement 21796 2New insight into RA patient priorities and motivators for clinical trial involvement 21796 3Express Scripts in Binding Agreement with MSC for the Purchase of its Pharmacy Services Division 21792 1Express Scripts in Binding Agreement with MSC for the Purchase of its Pharmacy Services Division 21792 2Express Scripts in Binding Agreement with MSC for the Purchase of its Pharmacy Services Division 21792 3Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 1Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 2Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 3Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 4Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 5Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 6Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 7Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 8Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 9Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 10Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 11Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 12Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 13Patients Taking Cymbalta 28R 29 Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study 2421 1Patients Taking Cymbalta 28R 29 Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study 2421 2Patients Taking Cymbalta 28R 29 Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study 2421 3Patients Taking Cymbalta 28R 29 Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study 2421 4Patients Taking Cymbalta 28R 29 Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study 2421 5
...at the Johns Hopkins Bloomberg School of Public He...r a variety of illnesses using genetically modifie...ctions. Oral adenovirus vaccines have long been pr...ieve their process for constructing a replicating ...nomical vaccines that provide longer-lasting disea...
...eport today in the journal Genome,Research that th...eviously intractable DNA sequence: a 554-kilobase-...man Y chromosome. This sequence,contains eight put...ex-associated height differences and gonadal tumor...f the few holes remaining in the,"finished" sequen...
...ave discovered that a protein that was originally ... resistance is actually a "missing enzyme" from th...cteria to scavenge iron. , The research appears as...he Journal of Biological Chemistry, an American So...al. , Mycobacterium tuberculosis, the causative a...
...pment in the analysis of cancer,has been announced... an,innovative method that enables the rapid advan... in cancer. According to the report,published in t...he,National Academy of Science (PNAS) in collabora...tute, Agilent has developed a specialised,microarr...
Other Biology News:Live Recombinant Adenovirus Vaccine Technique Explored 2Found: Missing sequence of the human Y chromosome 2Found: Missing sequence of the human Y chromosome 3Scientists find missing enzyme for tuberculosis iron scavenging pathway 2Breakthrough Microarray-based Technology for the Study of Cancer 2
(Date:7/8/2008)...IN FALLS, Ohio, July 8 /- Knowledge E...s announced today the release of The,2007-2008 Ort...ce for,objective, accurate, strategically oriented...summarizes the global orthopaedic market through,s...epair, Arthroscopy/Soft,Tissue Repair, Spinal Impl...
(Date:7/8/2008)...rgan-specific MRI Contrast Agent Approved in the U...n a Decade, WAYNE, N.J., July 8 /- B...diagnostic imaging, announced today that the U.S. ...VIST(R) (Gadoxetate Disodium),Injection, a gadolin...1-weighted magnetic resonance imaging (MRI) of the...
(Date:7/8/2008)...d and Management Focused on Near-Term Milestones a...Strategy, VANCOUVER and SAN DIEGO, July 8 /PRNews...FF), a clinical-stage developer of drugs for infec...pecial meeting of shareholders,for the purpose of ...(see,"Requisition of Shareholder Meeting"). Manage...
(Date:7/8/2008)... TechCFO, a leading provider of ou...es for technology and biotechnology companies, tod...rtner to its Boston office. Strickland is the late...ion, which opened in May of last year. , ... -- TechCFO, a leading provider of outsourced CFO...
Breaking Biology Technology:Knowledge Enterprises, Inc. and The Institute for Orthopaedics(TM) Release The 2007-2008 Orthopaedic Industry Annual Report 2FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions 2FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions 3FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions 4FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions 5FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions 6FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions 7MIGENIX Corporate Update and Requisition of Special Meeting 2MIGENIX Corporate Update and Requisition of Special Meeting 3MIGENIX Corporate Update and Requisition of Special Meeting 4MIGENIX Corporate Update and Requisition of Special Meeting 5MIGENIX Corporate Update and Requisition of Special Meeting 6MIGENIX Corporate Update and Requisition of Special Meeting 7MIGENIX Corporate Update and Requisition of Special Meeting 8TechCFO Adds Gary Strickland as Partner in Boston Office 2
...eviously reported initiative to establish a citywi...communities of Waukesha, Wauwatosa and Brookfield ...a are already being pitched by Cellnet, the provid...Milwaukee,s network is being built by a different ...stablished so far, the city is essentially leasing...
...student Pengpeng Zhang successfully imaged a piece... centimeter-in thickness, she and her UW-Madison c...ed thinking, the feat should be impossible because...ct electricity. , ,"After she did it, we realized,... thinner than what people normally use," says UW-...
... Third Wave Technologies has settled with a Belg...ng patents. Third Wave will license hepatitis C vi...ndisclosed financial terms. , ,The two companies, ... Wave forged a deal under which Innogenetics was a... line of products in Europe. It was Third Wave,s f...
... First Business Bank plans to launch a remote di...ne County. , ,Companies that purchased the service...over the Internet to the bank, where they would be... that First Business Bank president and COO Michae...c markets. , ,The service would eliminate trips to...
Other Biology Technology:Study explains unexpected conductivity of nanoscale silicon 2Study explains unexpected conductivity of nanoscale silicon 3
UBN-1 (C-20)
Rabbit polyclonal to Neuron navigator 1 ( Abpromise for all tested applications). Antigen: Synthetic peptide conjugated to KLH derived from within residues 1850 to the C-terminus of Mouse Neuron
Mouse HAI-1 Ectodomain MAb (Clone 199732)
pETDuet-1 is designed for the coexpression of two target genes.
Biology Products: